As obesity rates rise across the U.S., a new study from UnitedHealthcare and the Health Action Council examines the financial ...
Researchers at Columbia University Irving Medical Center have identified the specific neurons in mice brains that tell them ...
13h
News Medical on MSNObesity and cognition: Surprising study links higher BMI to better memoryHigher BMI in early adulthood and midlife is linked to better memory performance, particularly in men and Black Americans, ...
Scientists found brainstem neurons that tell mice when to stop eating, offering insights for obesity treatments. Columbia ...
Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...
The number of liver transplants performed due to obesity-related complications has tripled in the past seven years, according ...
Recognizing obesity as a chronic disease can improve treatment, address complications, and reshape healthcare strategies for ...
Eli Lilly and Novo Nordisk have both assuaged investor concerns over near-term growth. Now the focus shifts back to their ...
Is obesity a risk factor or a disease? This debate shapes treatments, policies, and eating disorder care. Explore its impact ...
Skye Bioscience, Inc. (NASDAQ:SKYE) is making waves in the biopharmaceutical industry with its innovative approach to obesity treatment. The company's lead candidate, nimacimab, a CB1 negative ...
A game-changer for obesity and heart failure? Dr Pandey reveals breakthrough GLP-1 trial results that show reduced cardiovascular risk and better outcomes for HFpEF patients. Don’t miss this!
Novo Nordisk defended its next-generation obesity drug candidate CagriSema on Wednesday following late-stage trial data ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results